Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Operating Leases (2019 - 2025)

Neurogene (NGNE) has disclosed Operating Leases for 4 consecutive years, with $7.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases changed N/A year-over-year to $7.1 million, compared with a TTM value of $7.1 million through Sep 2025, changed N/A, and an annual FY2024 reading of $9.4 million, changed N/A over the prior year.
  • Operating Leases was $7.1 million for Q3 2025 at Neurogene, down from $7.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $13.7 million in Q2 2024 and bottomed at $7.1 million in Q3 2025.